Personalized Medicine

The grant will prepare genetic counselors to contribute more fully to the advancement of personalized medicine. Nancy Cox, Ph.D., who directs the Vanderbilt Genetics Institute and the Division of Genetic Medicine, and Martha Dudek, M.S. CGC, director of the Vanderbilt Master of Genetic Counseling program, will serve as co-principal investigators. Read More

A new study sheds light on how molecular subsets within the tumors of kidney cancer patients determine treatment outcomes and underscores the importance of personalized medicine in making therapy decisions. Read More

On May 27, the All of Us Research Program launched the beta version of its cloud-based research platform, the Researcher Workbench. Read More

Vanderbilt University Medical Center investigators have used high-throughput robotic technology to rapidly study and classify variations in a gene linked to heart rhythm disorders and cardiac conditions. Read More

By defining the clinical and genetic factors that predict treatment response, Vanderbilt investigators aim to personalize therapy for a common heart complication in preterm infants. Read More

An international team of researchers led by Eric Gamazon has integrated gene expression and disease association data to better understand the biological mechanisms of complex human diseases. Read More

Vanderbilt University’s Dan Roden, MD, internationally known for his contributions to understanding how genetic variation affects drug response, has been named a recipient of the 2018 Louis and Artur Lucian Award for Research in Circulatory Diseases by McGill University in Montreal, Canada. Read More

More than 300 members of the Canby Robinson Society and the Vanderbilt University Medical Center community joined Jeff Balser, MD, PhD, and his wife, Melinda, last week at Cheekwood Estate and Gardens for a reception celebrating the community of supporters who help VUMC in “redefining personalized care.” Read More

On Sunday, May 6, Nashville played an important role in the nationwide launch of “All of Us,” the National Institutes of Health’s (NIH) research program that aims to collect the health information of 1 million or more research participants. Read More

In 1969 the United States was the first nation to land a man on the moon. Forty-nine years later this country is poised to take another “giant leap” for humankind, this time by unleashing a revolution in medical research and human health. Read More

A new digital-first storytelling initiative, Defining Personalized Care, highlights the personal impact everyone at Vanderbilt Health makes with patients, families and each other. Read More

A Vanderbilt-led research team has discovered genetic variations that increase the risk of heart attack even when patients are receiving a statin drug like Lipitor or Crestor to lower their blood cholesterol. Read More

The All of Us Research Program, which aims to accelerate the prevention and treatment of illness through precision medicine with the help of a million or more research participants across the United States, officially opens for national enrollment Sunday, May 6. Read More

“Big data” can help reverse the alarming decline in life expectancy in the United States — if universities and academic medical centers take the lead, former U.S. Food and Drug Administrator Robert Califf, MD, told a Vanderbilt audience last week. Read More

Officials with Vanderbilt University Medical Center announced the creation of a wholly owned subsidiary, Nashville Biosciences, to harness the power of its extensive genomic and bioinformatics resources to advance drug and diagnostics discovery and development. Read More

Vanderbilt University Medical Center (VUMC) has expanded and relaunched genetic testing to predict patient responses to drugs. Read More

Dan Roden, M.D., Senior Vice President for Personalized Medicine at Vanderbilt University Medical Center (VUMC), was named to receive the 2017 Medicine Alumni Global Lifetime Achievement Award by the Faculty of Medicine of his alma mater, McGill University. Read More

Personalized medicine is about tailoring treatment to individual patients based on their genetics. Georgia L. Wiesner, director of the Vanderbilt-Ingram Cancer Center’s Clinical and Translational Hereditary Cancer Program, explains the “4 Ps” of personalized medicine and the benefits it offers. Read More

“Someone in the NIH found the gas pedal and stepped on it,” said the keynote speaker for Personalized Medicine Day, held Sept. 23 at the Student Life Center. David Glazer, director of engineering at Verily Life Sciences, was remarking on the unusual velocity and momentum of the National Institutes of Health’s new Precision Medicine Initiative (PMI). Read More

Vanderbilt University Medical Center has been chosen by the National Institutes of Health to be a leader in a landmark study of genetic, environmental and lifestyle factors affecting the health of a million or more people. The NIH will provide $71.6 million over five years to VUMC, making this the largest research grant the Medical Center has ever received from any source. Read More